News
Tesla, Inc. Has Reportedly Sold Over a Third of Its Bond Offering
Tesla (NASDAQ: TSLA) CEO Elon Musk has been busy this week, hosting an investor event in Manhattan on Monday in connection with the electric-car marker's $1.5 billion bond offering. With his
Cheniere Energy Falls Back Into the Loss Column From One-Time Charges
Cheniere Energy (NYSEMKT: LNG) has been busy lately getting its Sabine Pass liquefied natural gas (LNG) facility up to speed. So far, it has been able to complete the first two phases of the
Why Ford Continues to Struggle in China
Ford Motor Company (NYSE: F) said that its sales in China fell 7% in July, as strong demand for the Blue Oval's commercial vehicles wasn't enough to offset a big slump in sales of small sedans. Ford
TrueCar Earnings: Loss Narrows Again as Improvements Take Hold
Online car-shopping service TrueCar (NASDAQ: TRUE) reported on Aug. 8 that it lost $8.1 million in the second quarter of 2017, or $0.09 per share, an improvement over the $14.7 million loss that it
Highlights From Iridium Communications’ Q2 2017 Report
Global telecommunications company Iridium Communications (NASDAQ: IRDM) turned in another solid business report card for the second quarter of 2017, but Wall Street has reacted negatively thus far
Which Disney Shows and Movies Will Netflix Be Losing?
Like many breakups, the one between Walt Disney (NYSE: DIS) and Netflix (NASDAQ: NFLX) might get a bit messy. The current deal, which began in 2016 and expires in 2019, gives Netflix exclusive
That Wasn't the Q2 That El Pollo Loco, Chuy's, or Texas Roadhouse Shareholders Ordered
In this segment from Motley Fool Money, host Chris Hill, Million Dollar Portfolio's Jason Moser and Total Income's Ron Gross peruse the menu of problems at two restaurant chains of the Mex and Tex
Finally! 3 Figures From Valeant's Second-Quarter Report That Demonstrate Improvement
If you've ever played the board game Chutes and Ladders and landed on space 87, which throws the player back 63 spaces, you might have some idea of what it's been like to be a Valeant Pharmaceuticals
TripAdvisor Deals With Competitive Pressures
TripAdvisor (NASDAQ: TRIP) has sought to stake its claim to the lucrative online travel business, moving beyond its initial focus on travel reviews to offer the same sorts of booking services that its
New Apple Inc. iPhone 8 Launch Details Emerge
Later this year, Apple (NASDAQ: AAPL) is expected to launch a trio of smartphones that could, in aggregate, help drive Apple's iPhone results past the peak that it enjoyed during the iPhone 6 "super
This Is the Real Reason to Love Northern Dynasty Minerals Stock
Northern Dynasty Minerals' (NYSEMKT: NAK) giant Pebble copper and gold mine project in Alaska was given a new lease on life following the election of Donald Trump. After stalling under the previous
Main Street Capital: Diving Into Second-Quarter Earnings
Business-development company Main Street Capital (NYSE: MAIN) reported that it earned $0.58 per share in net investment income, covering its distributions to investors during the second quarter. The
Why Plug Power Inc.'s Shares Popped in July (and Dropped in August)
Shares of Plug Power Inc. (NASDAQ: PLUG) jumped 10.8% in July, according to data from S&P Global Market Intelligence, after the company announced an expanded agreement with Wal-Mart (NYSE: WMT). The
Elon Musk Should Tell the Truth, the Whole Truth, and Nothing but the Truth
During its brief history, Tesla (NASDAQ: TSLA) has missed many self-imposed deadlines to bring products to market. It has also routinely fallen short of its annual production goals. These shortcomings
Why Boeing Soared More Than 22% in July
Shares of Boeing (NYSE: BA) jumped 22.6% in July. Although shares had been trending upward since the beginning of the month, the biggest bump came in the wake of the company's impressive
4 Reasons You Should Never, Ever Take a 401(k) Loan
If you've got a pressing financial concern and money in your 401(k), you may be tempted to take the cash out by taking a 401(k) loan. After all, the money is just sitting there, you'd be paying
How Safe Is Aflac's Dividend?
Most Americans know Aflac (NYSE: AFL) because of its duck-filled ads on television, with the specialty insurer offering a different type of insurance coverage from what most people get through their
This Marijuana Stock Skyrocketed Last Week, While 3 Others Plunged
When it comes to the market's top-performing stocks, you'd have a hard time topping marijuana stocks over the trailing year. A majority of pot stocks over the past 12 months have at least doubled in
Why Rising Lithium Production Could Crush Fertilizer Stocks
The world has all the lithium it needs, but will struggle to ramp up supply quickly enough to keep pace with expected demand in the next five to 10 years. That promises to keep selling prices high in
The 3 Best Buffett Stocks for Retirees
Quality and durability should be the two pillars of any retiree's stock portfolio. A company that has a long track record of success and a bright future thanks to durable competitive advantages is the
Why Consolidated Edison Is a Dividend Investor's Dream
Let's face it: Utilities are no one's idea of an exciting class of stocks. This is perhaps why Consolidated Edison (NYSE: ED) seldom makes investors' lists of top 10 picks.That's too bad, because it's
Is This Why bluebird bio Dipped 10.5% in July?
bluebird bio (NASDAQ: BLUE), a clinical-stage biotech focused on gene therapy, fell more than 10% in July, according to S&P Global Market Intelligence. However, there wasn't any news released during
Why Twitter's Ad Revenue Won't Pick Up in the Second Half of 2017
Twitter's (NYSE: TWTR) ad revenue has been in decline since the fourth quarter, and investors shouldn't expect that to change in the second half of the year, either. COO Anthony Noto told analysts on
Retiring Early? Here's How to Delay Taking Social Security Anyway
Sometimes retiring early is unavoidable. If you're struggling with chronic health issues, or if you're laid off from your job in your early 60s and see no prospect of getting another, it just makes
Celldex Therapeutics, Inc. Finishes Second Quarter With Plenty of Cash and Clinical Momentum
Investors view quarterly updates from clinical-stage biotechs in a much different way from how they view those of other companies. When Celldex Therapeutics (NASDAQ: CLDX) reported its first-quarter